Tweenvest Stocks

Lincoln Pharmaceuticals Limited (BSE: 531633)

Health Care · Pharmaceuticals · IN

Rs558.50

-4.06% today · +5.7% 1Y

Lincoln Pharmaceuticals Limited (BSE: 531633) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $115.59M.

Over the last twelve months the share price has gained 5.7%, trading between 439.95 and 770.00.

Tweenvest scores Lincoln Pharmaceuticals Limited across four factors: quality 83/100, value 59/100, growth 42/100, dividend 25/100. Its strongest factor is quality.

531633 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$115.59M
Revenue (TTM)
$73.43M
P/E
11.60
EPS
48.15
Dividend yield
0.32%
Beta (5Y)
0.47
52-week high
Rs770.00
52-week low
Rs439.95
Avg volume (3M)
—
Shares outstanding
20.03M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
KUKJEON Co.,LtdKOSDAQ: A307750$119.47M₩2,975.00+26.06%
Formosa Pharmaceuticals, Inc.TWSE: 6838$118.52MNT$25.10-0.79%
Hyloris Pharmaceuticals SAENXTBR: HYL$116.63M€4.00+7.53%
Ilsung Is Co., Ltd.KOSE: A003120$115.86M₩22,350.00+1.36%
Traphaco Joint Stock CompanyHOSE: TRA$115.29M₫36,000.00-1.77%
LENZ Therapeutics, Inc.NasdaqGS: LENZ$114.53M$3.63-0.41%
JW Shinyak CorporationKOSDAQ: A067290$114.08M₩2,745.00-7.42%
Fuso Pharmaceutical Industries,Ltd.TSE: 4538$113.91M¥2,113.00-0.09%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.